Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aim Immunotech Inc (AIM)

Aim Immunotech Inc (AIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,999
  • Shares Outstanding, K 40,686
  • Annual Sales, $ 140 K
  • Annual Income, $ -9,530 K
  • 60-Month Beta -0.94
  • Price/Sales 284.45
  • Price/Cash Flow N/A
  • Price/Book 1.33
Trade AIM with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.71 +19.30%
on 12/16/20
2.40 -15.00%
on 12/21/20
+0.28 (+15.91%)
since 12/15/20
3-Month
1.65 +23.64%
on 11/24/20
2.40 -15.00%
on 12/21/20
-0.27 (-11.69%)
since 10/15/20
52-Week
0.70 +191.43%
on 01/17/20
7.11 -71.31%
on 03/09/20
+1.30 (+177.55%)
since 01/15/20

Most Recent Stories

More News
AIM ImmunoTech Reschedules Investor Conference Call to January 21, 2021 at 11AM ET

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has rescheduled its investor conference call for 11:00 a.m. Eastern Time on Thursday, January 21, 2021 to discuss the recently announcedcommencement...

AIM : 2.04 (+0.99%)
AIM ImmunoTech Postpones Investor Conference Call. Will Reschedule for a Later Date

AIM ImmunoTech Inc. (NYSE American: AIM) and its CEO Thomas K. Equels today announced that this week's planned investor conference call will be postponed and rescheduled for a later date following the...

AIM : 2.04 (+0.99%)
AIM ImmunoTech Announces First COVID-19-Induced Chronic Fatigue "Long Hauler" Patient Dosed with Ampligen

AIM ImmunoTech Inc. (NYSE American: AIM) today announced that the active AMP-511 Expanded Access Program (EAP) has dosed its first COVID-19 "Long Hauler" patient with the drug Ampligen (rintatolimod),...

AIM : 2.04 (+0.99%)
AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 'Long Haulers'

AIM ImmunoTech Inc. (NYSE American: AIM) announced today that the post-COVID-19 "Long Hauler" portion of the active AMP-511 Expanded Access Program (EAP) protocol received approval from the Institutional...

AIM : 2.04 (+0.99%)
Thinking about buying stock in Pfizer, Senseonics Holdings, AIM ImmunoTech, Aileron Therapeutics, or Microvision?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, SENS, AIM, ALRN, and MVIS.

AIM : 2.04 (+0.99%)
SENS : 1.5800 (+31.67%)
ALRN : 1.8400 (-5.64%)
MVIS : 6.61 (+0.15%)
PFE : 36.70 (-0.14%)
AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 Long Haulers

AIM ImmunoTech Announces Availability of the ME/CFS Clinical Trial of its Drug Ampligen for Enrollment to COVID-19 'Long Haulers'

AIM : 2.04 (+0.99%)
Thinking about buying stock in Nantkwest, RealPage, Aerojet Rocketdyne, AIM ImmunoTech, or Corbus Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NK, RP, AJRD, AIM, and CRBP.

AIM : 2.04 (+0.99%)
CRBP : 1.7400 (unch)
NK : 17.25 (-3.04%)
RP : 87.03 (+0.36%)
AJRD : 52.46 (-0.47%)
Thinking about buying stock in Vistagen Therapeutics, Adapthealth, PainReform, Arbutus Biopharma, or AIM ImmunoTech?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VTGN, AHCO, PRFX, ABUS, and AIM.

AIM : 2.04 (+0.99%)
ABUS : 3.91 (-2.98%)
AHCO : 37.23 (-0.43%)
PRFX : 4.25 (-3.41%)
VTGN : 2.40 (+3.45%)
Thinking about buying stock in AIM ImmunoTech, Rockwell Medical, Transocean, Aurora Cannabis, or Wayfair?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AIM, RMTI, RIG, ACB, and W.

AIM : 2.04 (+0.99%)
ACB : 12.04 (+0.67%)
ACB.TO : 15.30 (+1.32%)
RIG : 3.28 (-6.02%)
W : 300.00 (-9.06%)
AIM ImmunoTech Receives Statistically Significant Positive Survival Results in Pancreatic Cancer from Erasmus University Medical Center, Rotterdam, Netherlands

Median survival approximately two-fold higher in Ampligen arm compared to historical controls; AIM to seek FDA Fast Track designation and orphan drug status in late stage pancreatic cancer

AIM : 2.04 (+0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM...

See More

Key Turning Points

3rd Resistance Point 2.20
2nd Resistance Point 2.14
1st Resistance Point 2.09
Last Price 2.04
1st Support Level 1.98
2nd Support Level 1.92
3rd Support Level 1.87

See More

52-Week High 7.11
Fibonacci 61.8% 4.66
Fibonacci 50% 3.90
Fibonacci 38.2% 3.15
Last Price 2.04
52-Week Low 0.70

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar